Thursday, August 28, 2025
News Health
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health
No Result
View All Result
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health
No Result
View All Result
HealthNews
No Result
View All Result
Home Health News

Moderna’s New Lower-Dose COVID-19 Vaccine Approved by FDA

June 4, 2025
in Health News
Share on FacebookShare on Twitter


News Picture: Moderna's New Lower-Dose COVID-19 Vaccine Approved by FDABy Stephanie Brown HealthDay Reporter

WEDNESDAY, June 4, 2025

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

The new vaccine (mNexspike [COVID-19 Vaccine, mRNA]) represents a significant step forward in the development of next-generation coronavirus vaccines, the Associated Press reported. The innovative design of mNexspike allows for a much lower dose, about one-fifth of the dosage used in the current vaccine (Spikevax), a reduction achieved by refining the vaccine’s target to elicit a more focused immune response.

The vaccine is not a replacement for the current Moderna COVID-19 vaccine. The lower-dose vaccine is intended to be a second option.

mNexspike is approved for use in individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years of age and older or 12 through 64 years of age with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19. This is the same limited use the FDA set in licensing the Novavax COVID-19 vaccine last month.

This fall, Moderna anticipates offering both Spikevax and mNexspike as COVID-19 vaccines. Their current vaccine, which is already available for individuals aged 6 months and older, does not currently have limitations on who can receive it, the AP reported.

The approval “adds an important new tool to help protect people at high risk of severe disease from COVID-19,” Stephane Bancel, Moderna CEO, said in a statement Saturday.

Approval of mNexspike was granted to Moderna.

MedicalNews
Copyright © 2025 HealthDay. All rights reserved.



Source link : https://www.medicinenet.com/modernas_new_lower_dose_covid_vaccine_approved/news.htm

Author :

Publish date : 2025-06-04 07:00:00

Copyright for syndicated content belongs to the linked Source.

Previous Post

Older Adults Are Using More Cannabis

Next Post

AI Pen Accurately Diagnoses Early PD via Handwriting

Related Posts

Health News

Flood of High-Level CDC Departures Follow Director’s Exit

August 28, 2025
Health News

Diversity in Med School Acceptances Dips Following Ruling

August 27, 2025
Health News

CDC Director Ousted After Just Weeks, Reports Say

August 27, 2025
Health News

Medical Schools, Residency Programs Need to Add More Nutrition Education, HHS Says

August 27, 2025
Health News

One in Seven Adults Started a GLP-1 Agent After Bariatric Surgery

August 27, 2025
Health News

How Can I Cultivate Healthcare Leadership Skills?

August 27, 2025
Load More

Flood of High-Level CDC Departures Follow Director’s Exit

August 28, 2025

Diversity in Med School Acceptances Dips Following Ruling

August 27, 2025

CDC Director Ousted After Just Weeks, Reports Say

August 27, 2025

Medical Schools, Residency Programs Need to Add More Nutrition Education, HHS Says

August 27, 2025

One in Seven Adults Started a GLP-1 Agent After Bariatric Surgery

August 27, 2025

How Can I Cultivate Healthcare Leadership Skills?

August 27, 2025

Brain Performance Varies With Menopausal Hormone Therapy

August 27, 2025

RFK Jr. Endorses Religious Exemptions for Vaccines

August 27, 2025
Load More

Categories

Archives

August 2025
MTWTFSS
 123
45678910
11121314151617
18192021222324
25262728293031
« Jul    

© 2022 NewsHealth.

No Result
View All Result
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health

© 2022 NewsHealth.

Go to mobile version